A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF

D. V. Tambourgi, T. L. Kipnis, W. D. Da Silva, Keith A Joiner, A. Sher, S. Heath, B. F. Hall, G. B. Ogden

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Resistance to complement-mediated lysis in Trypanosoma cruzi is due to the expression of complement-regulatory factors by the virulent developmental forms of this protozoan parasite. An 87- to 93-kDa molecule, which we have termed T-DAF (trypomastigote decay-accelerating factor), is present on the surface of the parasite and inhibits complement activation in a manner functionally similar to the mammalian complement regulatory component, decay- accelerating factor. In this report, we characterized monospecific polyclonal and monoclonal antibodies which were obtained from mice and rabbits immunized with fast protein liquid chromatography-purified T-DAF. These polyclonal antibodies were shown to inhibit T-DAF activity and were capable of inducing lysis of the parasites. Both the polyclonal and monoclonal antibodies were used to screen a cDNA expression library prepared from T. cruzi trypomastigote mRNA. From this library, we obtained a partial λgt11 cDNA clone which showed genetic and functional similarity to the human C3 convertase inhibitor DAF (A. Nicholson-Weller, J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen, J. Immunol. 129:184-189, 1982).

Original languageEnglish (US)
Pages (from-to)3656-3663
Number of pages8
JournalInfection and Immunity
Volume61
Issue number9
StatePublished - 1993
Externally publishedYes

Fingerprint

Complement Inactivating Agents
CD55 Antigens
Trypanosoma cruzi
Complementary DNA
Clone Cells
Parasites
Complement C3-C5 Convertases
Monoclonal Antibodies
Complement Activation
Gene Library
Liquid Chromatography
Libraries
Rabbits
Messenger RNA
Antibodies

ASJC Scopus subject areas

  • Immunology

Cite this

A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. / Tambourgi, D. V.; Kipnis, T. L.; Da Silva, W. D.; Joiner, Keith A; Sher, A.; Heath, S.; Hall, B. F.; Ogden, G. B.

In: Infection and Immunity, Vol. 61, No. 9, 1993, p. 3656-3663.

Research output: Contribution to journalArticle

@article{931613200a9048058adcebb79074afd9,
title = "A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF",
abstract = "Resistance to complement-mediated lysis in Trypanosoma cruzi is due to the expression of complement-regulatory factors by the virulent developmental forms of this protozoan parasite. An 87- to 93-kDa molecule, which we have termed T-DAF (trypomastigote decay-accelerating factor), is present on the surface of the parasite and inhibits complement activation in a manner functionally similar to the mammalian complement regulatory component, decay- accelerating factor. In this report, we characterized monospecific polyclonal and monoclonal antibodies which were obtained from mice and rabbits immunized with fast protein liquid chromatography-purified T-DAF. These polyclonal antibodies were shown to inhibit T-DAF activity and were capable of inducing lysis of the parasites. Both the polyclonal and monoclonal antibodies were used to screen a cDNA expression library prepared from T. cruzi trypomastigote mRNA. From this library, we obtained a partial λgt11 cDNA clone which showed genetic and functional similarity to the human C3 convertase inhibitor DAF (A. Nicholson-Weller, J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen, J. Immunol. 129:184-189, 1982).",
author = "Tambourgi, {D. V.} and Kipnis, {T. L.} and {Da Silva}, {W. D.} and Joiner, {Keith A} and A. Sher and S. Heath and Hall, {B. F.} and Ogden, {G. B.}",
year = "1993",
language = "English (US)",
volume = "61",
pages = "3656--3663",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF

AU - Tambourgi, D. V.

AU - Kipnis, T. L.

AU - Da Silva, W. D.

AU - Joiner, Keith A

AU - Sher, A.

AU - Heath, S.

AU - Hall, B. F.

AU - Ogden, G. B.

PY - 1993

Y1 - 1993

N2 - Resistance to complement-mediated lysis in Trypanosoma cruzi is due to the expression of complement-regulatory factors by the virulent developmental forms of this protozoan parasite. An 87- to 93-kDa molecule, which we have termed T-DAF (trypomastigote decay-accelerating factor), is present on the surface of the parasite and inhibits complement activation in a manner functionally similar to the mammalian complement regulatory component, decay- accelerating factor. In this report, we characterized monospecific polyclonal and monoclonal antibodies which were obtained from mice and rabbits immunized with fast protein liquid chromatography-purified T-DAF. These polyclonal antibodies were shown to inhibit T-DAF activity and were capable of inducing lysis of the parasites. Both the polyclonal and monoclonal antibodies were used to screen a cDNA expression library prepared from T. cruzi trypomastigote mRNA. From this library, we obtained a partial λgt11 cDNA clone which showed genetic and functional similarity to the human C3 convertase inhibitor DAF (A. Nicholson-Weller, J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen, J. Immunol. 129:184-189, 1982).

AB - Resistance to complement-mediated lysis in Trypanosoma cruzi is due to the expression of complement-regulatory factors by the virulent developmental forms of this protozoan parasite. An 87- to 93-kDa molecule, which we have termed T-DAF (trypomastigote decay-accelerating factor), is present on the surface of the parasite and inhibits complement activation in a manner functionally similar to the mammalian complement regulatory component, decay- accelerating factor. In this report, we characterized monospecific polyclonal and monoclonal antibodies which were obtained from mice and rabbits immunized with fast protein liquid chromatography-purified T-DAF. These polyclonal antibodies were shown to inhibit T-DAF activity and were capable of inducing lysis of the parasites. Both the polyclonal and monoclonal antibodies were used to screen a cDNA expression library prepared from T. cruzi trypomastigote mRNA. From this library, we obtained a partial λgt11 cDNA clone which showed genetic and functional similarity to the human C3 convertase inhibitor DAF (A. Nicholson-Weller, J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen, J. Immunol. 129:184-189, 1982).

UR - http://www.scopus.com/inward/record.url?scp=0027198268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027198268&partnerID=8YFLogxK

M3 - Article

C2 - 7689538

AN - SCOPUS:0027198268

VL - 61

SP - 3656

EP - 3663

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 9

ER -